Aclarion, Inc. (ACONW) stock
ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $5.62MP/E –Yield –
Aclarion operating margin
Operating margin is operating income as a percentage of revenue.
Aclarion's operating margin for the twelve months ending Jun 30, 2026 was -11592.1%. For fiscal 2025 it was -9312.5%, against -12057.2% the year before. The highest annual figure on record is -4897.9% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9312.5% | +2744.7 |
| FY2024 | Dec 31, 2024 | -12057.2% | −5590.8 |
| FY2023 | Dec 31, 2023 | -6466.5% | +2734.7 |
| FY2022 | Dec 31, 2022 | -9201.2% | −4303.3 |
| FY2021 | Dec 31, 2021 | -4897.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -11503.2% | −2514.6 |
| Q1 FY2026 | Mar 31, 2026 | -14129.3% | −6273.4 |
| Q4 FY2025 | Dec 31, 2025 | -10785.2% | +6867.5 |
| Q3 FY2025 | Sep 30, 2025 | -9666.2% | −670.8 |
| Q2 FY2025 | Jun 30, 2025 | -8988.6% | +1362.0 |
| Q1 FY2025 | Mar 31, 2025 | -7856.0% | +4753.4 |
| Q4 FY2024 | Dec 31, 2024 | -17652.7% | −9489.0 |
| Q3 FY2024 | Sep 30, 2024 | -8995.3% | −2899.5 |
| Q2 FY2024 | Jun 30, 2024 | -10350.6% | −2113.7 |
| Q1 FY2024 | Mar 31, 2024 | -12609.3% | −7971.5 |
| Q4 FY2023 | Dec 31, 2023 | -8163.7% | −3978.7 |
| Q3 FY2023 | Sep 30, 2023 | -6095.9% | +2867.3 |
| Q2 FY2023 | Jun 30, 2023 | -8236.9% | +685.4 |
| Q1 FY2023 | Mar 31, 2023 | -4637.9% | +2700.0 |
| Q4 FY2022 | Dec 31, 2022 | -4185.0% | −1739.2 |
| Q3 FY2022 | Sep 30, 2022 | -8963.1% | −5070.1 |
| Q4 FY2021 | Dec 31, 2021 | -8922.3% | – |
| Q3 FY2021 | Sep 30, 2021 | -7337.8% | – |
| Q2 FY2021 | Jun 30, 2021 | -2445.8% | – |
| Q1 FY2021 | Mar 31, 2021 | -3893.0% | – |